Arch Therapeutics (ARTH, $0.2) was one of top quarterly gainers, jumping +1 to $0.2 per share. A.I.dvisor analyzed 847 stocks in the Biotechnology Industry over the last three months, and discovered that of them (2) charted an Uptrend while of them (7) trended down.